(PS) Schmitz v. Asman

District Court, E.D. California·Decided June 25, 2020·No. 2:20-cv-00195·Unknown

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 FOR THE EASTERN DISTRICT OF CALIFORNIA 10 11 THOMAS SCHMITZ, et al., No. 2:20-cv-00195-JAM-CKD PS 12 Plaintiffs, 13 v. ORDER 14 A. ASMAN, et al., (ECF Nos. 22, 23, 33) 15 Defendants. 16 17 Presently before the court are defendants’ motions to dismiss, to which plaintiffs have 18 responded, as well as plaintiffs’ motion to reconsider the Clerk’s denial of plaintiffs’ request to 19 enter default against defendant Golding.1 (ECF Nos. 22, 23, 33.) A hearing on these motions was 20 held on June 17, 2020. (ECF No. 40.) Plaintiffs appeared at the hearing individually, and Jennifer 21 Nygaard appeared for defendants. As set forth below, the court GRANTS IN PART and DENIES 22 IN PART defendants’ motions to dismiss and DENIES plaintiffs’ motion to reconsider. 23 //// 24 //// 25 //// 26

27 1 Plaintiffs are proceeding pro se, and this action is before the undersigned pursuant to Eastern District of California Local Rule 302(c)(21). 28 1 BACKGROUND2 2 This matter concerns the death of William Schmitz (“Decedent”) while incarcerated at Mule 3 Creek State Prison (“MCSP”). Generally, plaintiffs—Decedent’s mother and father—allege that 4 Decedent was removed from critical antipsychotic medications and the prison’s Enhanced 5 Outpatient Program (EOP)—a high-level outpatient psychiatric care program—and that these two 6 decisions resulted in Decedent’s death via methamphetamine overdose on January 21, 2019.3 (ECF 7 No. 6 at 3-4.) 8 Decedent had a long history of mental illness and schizophrenia, conditions which led him 9 into withdrawal and to self-medicate with illicit drugs. (Id. at 3, 14.) Decedent was incarcerated 10 for shooting and killing a man while in a psychotic state; he was in CDCR custody from February 11 2009 until his death. (Id. at 14.) From the start of his incarceration until May 2018 Decedent was 12 in EOP—the highest level of outpatient psychiatric care for mentally disordered inmate-patients. 13 (Id.) Around June 2014 Decedent was prescribed, and responded well to, Clozapine, a medication 14 used to treat psychotic disorders that are not adequately treated with “other safer antipsychotics.” 15 (Id. at 15.) However, Decedent’s prescription to Clozapine was stopped as a result of Decedent 16 developing hepatitis. (Id. at 16.) Decedent was then prescribed Paliperidone, to which he also 17 responded well. (Id. at 17.) 18 In May 2017, Decedent was transferred to dormitory housing “despite recommendations 19 against dormitory housing by mental health providers.” (Id.) This change was stressful for 20 Decedent and caused his psychosis to worsen. (Id.) 21 On September 1, 2017, Decedent received a disciplinary action for possession of drug 22 paraphernalia. (Id. at 21.) The mental healthcare team did not know of this incident until five 23 2 Unless otherwise indicated, the factual background is taken from plaintiffs’ First Amended 24 Complaint. (ECF No. 6.)

25 3 It is unclear whether plaintiffs assert Decedent’s death was an accidental overdose or a suicide. (See ECF No. 6 at 31 (“[Decedent’s] death seemed to meet CDCR[’s] definition of suicide ‘an 26 intentional self-injurious behavior that causes or leads to one’s own death.’ However, the most 27 convenient scenario for MCSP was to have [Decedent’s] death be an accident due to drug smuggling, for the drugs to be provided by an outside visitor and to avoid any mention of his 28 severe mental illness.”).) 1 months later. (Id.) From plaintiffs’ complaint, it appears that Decedent began treating with Dr. 2 Robinson around January 2018, who noted that Decedent’s “chronic risk of suicide was high and 3 acute risk of suicide was moderate.” (Id.) Dr. Robinson also noted that Decedent was experiencing 4 anxiety and was non-compliant with medication. (Id.) 5 On January 31, 2018, Decedent was treated by psychiatrist Dr. Ramkumar. (Id. at 22.) 6 Because Decedent was caught with drug paraphernalia, as mentioned above, Dr. Ramkumar 7 ordered Decedent to take a drug screening, which Decedent refused. (Id.) Dr. Robinson and 8 Decedent subsequently discussed Decedent’s drug use, his continued enrollment in EOP, and his 9 “low treatment adherence.” (Id. at 22-23.) Dr. Robinson was “focused on moving [Decedent] to a 10 lower level of care[,] not treating his mental illness or drug dependence.” (Id. at 23.) Decedent 11 was subsequently transferred “to a lower level of psychiatric care” with the stated reason being that 12 Decedent had poor attendance in EOP groups. (Id.) However, Decedent’s poor attendance was a 13 result of him “decompressing as his psychiatric medications were lowered.” (Id. at 24.) 14 Decedent’s records reflect a notation on April 12, 2018 that Decedent stopped taking 15 medications, although he subsequently restarted. (Id.) Although Decedent wished to remain in 16 EOP, he was transferred from EOP to Correctional Clinical Case Management Systems 17 (“CCCMS”) because it would “help CDCR look better on their healthcare monitoring metrics and 18 give the appearance of better care than actually provided.” (Id. at 24-25.) 19 Following Decedent’s transfer, Dr. R. Johnson “completely stopped [Decedent’s] 20 antipsychotic medications.” (Id. at 26.) Dr. M. Smith diagnosed Decedent with “antisocial and 21 borderline personality disorder,” noting the medications “Invega, Thorazine, Haldol, Lithium, 22 Clozaril, Zyprexa, Depakote, Wellbutrin, Topamax, and Trileptal” were “noteworthy for their 23 ineffectiveness.” (Id. at 26-27.) This was contrary to Decedent’s medical history. (Id.) Dr. M. 24 Smith’s “misdiagnosis poisoned [Decedent’s] medical record for future providers.” (Id.) 25 On July 2, 2018, Eric Branman reported that Decedent was able to sleep after being awake 26 for two days, and that the staff suspected Decedent was abusing drugs. (Id.) On December 7, 2018, 27 Decedent had his first visit with Dr. Andaluz, who noted that Decedent originally refused his 28 appointment, had limited engagement, and had been prescribed multiple psychiatric medications 1 but none of them were effective. (Id. at 27-28.) Subsequently, on January 4, 2019, Dr. Andaluz 2 noted that Decedent was “worried about losing dorm exclusion” and that Decedent stated he “deals 3 with a lot of paranoia and psychosis.” (Id. at 28.) Dr. Andaluz did not make any recommendation 4 for increased monitoring or to restart antipsychotics; rather, the medication Dr. Andaluz prescribed 5 Decedent may cause hallucinations. (Id.) 6 On January 17, 2019, Decedent met with social worker Violka Wanie. (Id at 29.) Wanie 7 noted that Decedent denied that his psychosis was substance induced, but Decedent told her that he 8 “self-medicated when [he] started hearing voices to help [him] deal with them.” (Id.) Wanie took 9 no action as a result of these reports from Decedent. (Id.) 10 Decedent’s last reported interaction was with Officer Asman, who questioned Decedent 11 after Asman saw water flowing from Decedent’s cell. (Id.) Asman did not inspect Decedent’s cell 12 or investigate further. (Id.) Decedent’s body was found approximately eight hours later, on January 13 21, 2019; Decedent’s apparent cause of death was methamphetamine overdose. (Id.) 14 Plaintiffs’ First Amended Complaint (“FAC”) includes various acts and omissions that 15 plaintiffs allege demonstrate a cover-up to deflect from the true cause of Decedent’s death. (See 16 id. at 30-31.) Plaintiffs also assert that Decedent’s “death occurred at a particularly inconvenient 17 time for MCSP” as it was “desperately trying to get out from under the court injunction as a result 18 of [the] Coleman v. Brown lawsuit.” (Id. at 31.) 19 Plaintiffs filed the present suit on January 27, 2020 and filed their FAC on February 26, 20 2020. (ECF Nos. 1, 6.) Defendants filed motions to dismiss on May 4, 2020 and May 15, 2020, 21 which are presently before the court. (ECF Nos.

Free access — add to your briefcase to read the full text and ask questions with AI

(PS) Schmitz v. Asman, (E.D. Cal. 2020).

(PS) Schmitz v. Asman ((PS) Schmitz v. Asman) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Scheuer v. Rhodes
416 U.S. 232 (Supreme Court, 1974)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Simmons v. Navajo County, Ariz.
609 F.3d 1011 (Ninth Circuit, 2010)
Wilkinson v. Torres
610 F.3d 546 (Ninth Circuit, 2010)
Dougherty v. City of Covina
654 F.3d 892 (Ninth Circuit, 2011)
Toguchi v. Soon Hwang Chung
391 F.3d 1051 (Ninth Circuit, 2004)
Wilhelm v. Rotman
680 F.3d 1113 (Ninth Circuit, 2012)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Pinney & Boyle Co. v. Los Angeles Gas & Electric Corp.
141 P. 620 (California Supreme Court, 1914)
Liberty Nat. Bank of Roanoke v. Bear
4 F.2d 240 (Fourth Circuit, 1925)
Cato v. United States
70 F.3d 1103 (Ninth Circuit, 1995)
Lopez v. Smith
203 F.3d 1122 (Ninth Circuit, 2000)